At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 100 enrolled
Drug / intervention
Dexmedetomidinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Pain and Comfort in Patients Following Cardiac Surgery: Opioid- Morphine Managed Versus Multimodal Pain-management
In Brief
A Phase 4 clinical trial evaluating Dexmedetomidine for Postoperative Pain and Postoperative Delirium. Completed, enrolled 100 participants across 1 site.
Detailed Summary
To compare standard "Fentanyl - Tramadol - Paracetamol - Oxycodone" regimen to a multimodal painmanagement "pregabalin- minimal fentanyl-ketamine-lidocain-dexmedetomidine- paracetamol" to determine which therapy provides the most comfort, the fastest extubation time, the least pain and the least delirium.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Pain, Postoperative Delirium
CountriesBelgium
Collaborators--
Timeline
Phase 4CompletedFinished
20192020202120222023202420252026
Enrollment StartJan 2019
First PostedAug 2021
Primary CompletionDec 2021
Study CompletionDec 2021
TodayJul 2026
First PostedAug 3, 2021
Enrollment StartJan 21, 2019
Primary CompletionDec 1, 2021
Study CompletionDec 3, 2021
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 4.9 years ago
Interventions
Dexmedetomidinedrug
The use of multimodal painkillers pre, per and postoperative